FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


10679 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
bifasiskt humant isofaninsulin 40/60, 100 E/ml, injektionsvätska, lösning, cylinderampull 1,5 ml Product containing precisely human isophane insulin 60 unit/1 milliliter and recombinant human regular insulin 40 unit/1 milliliter conventional release suspension for injection (clinical drug)
bifasiskt humant isofaninsulin 40/60, 100 E/ml, injektionsvätska, lösning, cylinderampull 3 ml Product containing precisely human isophane insulin 60 unit/1 milliliter and recombinant human regular insulin 40 unit/1 milliliter conventional release suspension for injection (clinical drug)
bifasiskt humant isofaninsulin 40/60, 100 E/ml, injektionsvätska, lösning, förfylld penna 3 ml Product containing precisely human isophane insulin 60 unit/1 milliliter and recombinant human regular insulin 40 unit/1 milliliter conventional release suspension for injection (clinical drug)
bifasiskt humant isofaninsulin 50/50, 100 E/ml, injektionsvätska, lösning, cylinderampull 1,5 ml Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug)
bifasiskt humant isofaninsulin 50/50, 100 E/ml, injektionsvätska, lösning, flaska 10 ml Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug)
bifasiskt humant isofaninsulin 50/50, 100 E/ml, injektionsvätska, lösning, cylinderampull 3 ml Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug)
bifasiskt humant isofaninsulin 50/50, 100 E/ml, injektionsvätska, lösning, förfylld penna 3 ml Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug)
bifasiskt humant isofaninsulin 50/50, 100 E/ml, injektionsvätska, lösning, flaska 5 ml Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug)
bifasiskt porcint isofaninsulin 30/70, 100 E/ml, injektionsvätska, lösning, flaska 10 ml Product containing precisely porcine isophane insulin 70 unit/1 milliliter and porcine regular insulin 30 unit/1 milliliter conventional release suspension for injection (clinical drug)
bifasiskt lisproinsulin 25/75, 100 E/ml, injektionsvätska, lösning, cylinderampull 3 ml Product containing precisely insulin lispro 25 unit/1 milliliter and insulin lispro protamine 75 unit/1 milliliter conventional release solution for injection (clinical drug)
bifasiskt lisproinsulin 25/75, 100 E/ml, injektionsvätska, lösning, förfylld penna 3 ml Product containing precisely insulin lispro 25 unit/1 milliliter and insulin lispro protamine 75 unit/1 milliliter conventional release solution for injection (clinical drug)
bifasiskt lisproinsulin 50/50, 100 E/ml, injektionsvätska, lösning, förfylld penna 3 ml Product containing precisely insulin lispro 50 unit/1 milliliter and insulin lispro protamine 50 unit/1 milliliter conventional release solution for injection (clinical drug)
Insulin isophane biphasic human 10/90 100units/ml injection 1.5ml cartridge Product containing precisely human isophane insulin 90 unit/1 milliliter and recombinant human regular insulin 10 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 10/90 100units/ml injection 3ml pre-filled disposable injection device Product containing precisely human isophane insulin 90 unit/1 milliliter and recombinant human regular insulin 10 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 15/85 100units/ml injection 5ml vial Product containing precisely human isophane insulin 85 unit/1 milliliter and recombinant human regular insulin 15 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 20/80 100units/ml injection 3ml cartridge Product containing precisely human isophane insulin 80 unit/1 milliliter and recombinant human regular insulin 20 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 20/80 100units/ml injection 3ml pre-filled disposable injection device Product containing precisely human isophane insulin 80 unit/1 milliliter and recombinant human regular insulin 20 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 25/75 100units/ml injection 3ml pre-filled disposable injection device Product containing precisely human isophane insulin 75 unit/1 milliliter and recombinant human regular insulin 25 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 25/75 100units/ml injection 5ml vial Product containing precisely human isophane insulin 75 unit/1 milliliter and recombinant human regular insulin 25 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 30/70 100units/ml injection 10ml vial Product containing precisely human isophane insulin 70 unit/1 milliliter and recombinant human regular insulin 30 unit/1 milliliter conventional release solution for injection (clinical drug)
Insulin isophane biphasic human 30/70 100units/ml injection 3ml pre-filled disposable injection device Product containing precisely human isophane insulin 70 unit/1 milliliter and recombinant human regular insulin 30 unit/1 milliliter conventional release solution for injection (clinical drug)
Insulin isophane biphasic human 40/60 100units/ml injection 3ml cartridge Product containing precisely human isophane insulin 60 unit/1 milliliter and recombinant human regular insulin 40 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 40/60 100units/ml injection 3ml pre-filled disposable injection device Product containing precisely human isophane insulin 60 unit/1 milliliter and recombinant human regular insulin 40 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 50/50 100units/ml injection 10ml vial Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 50/50 100units/ml injection 3ml cartridge Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 50/50 100units/ml injection 3ml pre-filled disposable injection device Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 50/50 100units/ml injection 5ml vial Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic porcine 30/70 100units/ml injection 10ml vial Product containing precisely porcine isophane insulin 70 unit/1 milliliter and porcine regular insulin 30 unit/1 milliliter conventional release suspension for injection (clinical drug)
bovint isofaninsulin, 100 E/ml, injektionsvätska, lösning, cylinderampull 1,5 ml Bovine isophane insulin 100 unit/mL suspension for injection
porcint isofaninsulin, 100 E/ml, injektionsvätska, lösning, cylinderampull 1,5 ml Product containing precisely porcine isophane insulin 100 unit/1 milliliter conventional release suspension for injection (clinical drug)
porcint isofaninsulin, 100 E/ml, injektionsvätska, lösning, flaska 10 ml Product containing precisely porcine isophane insulin 100 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane porcine 100units/ml injection 10ml vial Product containing precisely porcine isophane insulin 100 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin lispro biphasic (recombinant human insulin analogue) human 25/75 100units/ml injection 3ml cartridge Product containing precisely insulin lispro 25 unit/1 milliliter and insulin lispro protamine 75 unit/1 milliliter conventional release solution for injection (clinical drug)
porcint lösligt insulin, 100 E/ml, injektionsvätska, lösning, cylinderampull 1,5 ml Product containing precisely porcine regular insulin 100 unit/1 milliliter conventional release solution for injection (clinical drug)
biverkning av amorf zinkinsulinsuspension Adverse reaction to zinc insulin
biverkning av kristallin zinkinsulinsuspension Adverse reaction to zinc insulin
allergi mot kristallin zinkinsulinsuspension Allergy to zinc insulin
biverkning av zinkinsulinsuspension Adverse reaction to zinc insulin
Intact parathyrin Parathyroid hormone
integrerad muskuloskeletal frigöring Osteopathic combined treatment method (procedure)
Intentional X-ray contrast media overdose Intentional X-ray diagnostic contrast media overdose
Intentional X-ray contrast media poisoning Intentional X-ray diagnostic contrast media overdose
avsiktlig överdos av disulfiram Intentional disulfiram overdose (disorder)
avsiktlig disulfiramförgiftning Intentional disulfiram poisoning (disorder)
Intentional chlorprothixene overdose Intentional chlorprothixene overdose (disorder)
avsiktlig överdos av natriumvalproat Intentional valproate overdose (disorder)
Intentional pesticide product overdose Intentional pesticide product poisoning
avsiktlig överdos av natriumfusidat Intentional fusidic acid overdose
avsiktlig warfarinöverdos Intentional warfarin overdose (disorder)
Intentional zuclopenthixol overdose Intentional chlorprothixene overdose (disorder)
Interdigital pilonidal sinus Barber's pilonidal sinus
interferon alfa-2b 10 miljoner IE, pulver och vätska till injektionslösning, flaska Interferon alfa-2b only product in parenteral dose form
interferon alfa-2b 10 miljoner IE, pulver till injektionsvätska, lösning, flaska Interferon alfa-2b only product in parenteral dose form
interferon alfa-2b 10 miljoner IE/ml, injektionsvätska, lösning, flaska 2,5 ml Product containing precisely interferon alfa-2b 10 million unit/1 milliliter conventional release solution for injection (clinical drug)
interferon alfa-2b 18 miljoner IE/flaska, lösning Interferon alfa-2b only product
Interferon alfa-2b 18million/iu solution Interferon alfa-2b only product
Interferon alfa-2b 18mu/vial Interferon alfa-2b only product
interferon alfa-2b 25 miljoner IE/flaska, lösning Interferon alfa-2b only product
interferon alfa-2b 3 miljoner IE/flaska, lösning Interferon alfa-2b only product
interferon alfa-2b 30 miljoner IE, lösning Interferon alfa-2b only product
interferon alfa-2b 3 miljoner IE, pulver och vätska till injektionslösning, flaska Interferon alfa-2b only product in parenteral dose form
interferon alfa-2b 3 miljoner IE, pulver till injektionsvätska, lösning, flaska Interferon alfa-2b only product in parenteral dose form
interferon alfa-2b 5 miljoner IE/flaska, lösning Interferon alfa-2b only product
interferon alfa-2b 5 miljoner IE, pulver och vätska till injektionslösning, flaska Interferon alfa-2b only product in parenteral dose form
interferon alfa-2b 5 miljoner IE, pulver till injektionsvätska, lösning, flaska Interferon alfa-2b only product in parenteral dose form
interferon alfa-2b 60 miljoner IE, lösning Interferon alfa-2b only product
interferon alfa-n3 från humana leukocyter 5 miljoner enheter/ml, injektionsvätska, lösning, flaska 1 ml Product containing precisely interferon alfa-n3 5 million unit/1 milliliter conventional release solution for injection (clinical drug)
interferon beta-1a 12 miljoner IE/ml, injektionslösning, förfylld spruta 0,5 ml Interferon beta-1a 30 microgram/mL solution for injection
interferon beta-1a 24 miljoner IE/ml, injektionslösning, förfylld spruta 0,5 ml Interferon beta-1a 24 million unit/mL solution for injection
Interferon beta-1a 30mcg/vial injection Product containing precisely interferon beta-1a 30 microgram/1 vial powder for conventional release solution for injection (clinical drug)
interferon beta-1a 30 mikrogram/injektionsflaska, injektionsvätska, lösning Product containing precisely interferon beta-1a 30 microgram/1 vial powder for conventional release solution for injection (clinical drug)
interferon beta-1a 6 miljoner IE, pulver och vätska till injektionslösning, flaska Interferon beta-1a only product in parenteral dose form
interferon beta-1a 6 miljoner IE, pulver till injektionsvätska, lösning, flaska Interferon beta-1a only product in parenteral dose form
interferon beta 1-b 100 mikrogram, injektionsvätska, lösning Product containing only interferon beta-1b in parenteral dose form (medicinal product form)
interferon beta-1b 8 miljoner IE, pulver och vätska till injektionslösning, flaska Product containing only interferon beta-1b in parenteral dose form (medicinal product form)
interferon beta-1b 8 miljoner IE, pulver till injektionsvätska, lösning, flaska Product containing only interferon beta-1b in parenteral dose form (medicinal product form)
interimsrapport Interim report (record artifact)
intermediär faktor VIII-fraktion, 250 IE, pulver och vätska till injektionslösning, flaska Coagulation factor VIII only product
intermediär faktor VIII-fraktion, 500 IE, pulver och vätska till injektionslösning, flaska Coagulation factor VIII only product
Angiography of internal carotid arteries, bilateral Angiography of cervicocerebral arteries
Intermediate lobe of right lung Structure of middle lobe of right lung (body structure)
intermediär metaboliserare på grund av cytokrom p450, variant CYP2C19 CYP2C19 intermediate metabolizer
intermediär metaboliserare på grund av cytokrom P450, variant CYP2D6 Cytochrome P450 family 2 subfamily D member 6 intermediate metabolizer (finding)
Internal fixation of mandible with arch bars External fixation of mandible with arch bars (procedure)
intern fixering av underkäken med bågstänger External fixation of mandible with arch bars (procedure)
Internal granuloma of pulp Internal resorption of tooth
intern migration Transuterine migration (finding)
Internal resorption of crown of tooth Internal resorption of tooth
cervixcancer FIGO-stadium 0 FIGO stage finding for cervical carcinoma
Intersphincteric anal canal dissection Dissection - action
Intertarsal joint Intertarsal joint structure
Intervertebral disc extrusion Intervertebral disc prolapse
Intestinal infection due to Enterobacter aerogenes Intestinal infection caused by Klebsiella aerogenes
Intestinal infection due to other organisms Infectious enteritis of intestine
Intra-amniotic fetal infection Intra-amniotic infection of fetus
Intracranial hemorrhage following injury with open intracranial wound and unspecified state of consciousness Intracranial hemorrhage following injury with open intracranial wound
intracystiskt karcinom Encapsulated papillary carcinoma (morphologic abnormality)
intraduktalt carcinoma in situ Non-infiltrating intraductal carcinoma
intraduktal papillär-mucinös tumör med måttlig dysplasi Intraductal papillary-mucinous adenoma (morphologic abnormality)
allergi mot intramuskulärt testosteron Allergy to testosterone
Intranasal intubation of lacrimal apparatus for tear drainage Intranasal intubation of lacrimal drainage system for tear drainage (procedure)

Start Previous Page 45 of 107 Next End


Reference Sets

Reference set descriptor

Back to Start